Compounds > verbascose
Page last updated: 2024-12-08

verbascose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

verbascose: a pentasaccharide from developing pea (Pisum sativum L.) seeds [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

verbascose : A pentasaccharide that is stachiose which has an additional unit of alpha-D-galactopyranose attached by a 1->6 glycosidic linkage to the terminal galactosyl residue. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID441434
CHEBI ID28586
SCHEMBL ID38437
MeSH IDM0572023

Synonyms (27)

Synonym
alpha-d-glucopyranoside, beta-d-fructofuranosyl o-alpha-d-galactopyranosyl-(1-6)-o-alpha-d-galactopyranosyl-(1-6)-o-alpha-d-galactopyranosyl-(1-6)-
75493766s3 ,
unii-75493766s3
d-verbascose
einecs 208-905-4
verbascose
546-62-3
C08252
beta-d-fructofuranosyl o-alpha-d-galactopyranosyl-(1-6)-o-alpha-d-galactopyranosyl-(1-6)-o-alpha-d-galactopyranosyl-(1-6)-alpha-d-glucopyranoside
alpha-d-galp-(1->6)-alpha-d-galp-(1-6)-alpha-d-galp-(1->6)-alpha-d-glcp-(1->2)-beta-d-fruf
(2s,3r,4s,5r,6r)-2-[[(2r,3r,4s,5r,6s)-6-[[(2r,3r,4s,5r,6s)-6-[[(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6
AC1L9B5S ,
CHEBI:28586
beta-d-fructofuranosyl alpha-d-galactopyranosyl-(1->6)-alpha-d-galactopyranosyl-(1->6)-alpha-d-galactopyranosyl-(1->6)-alpha-d-glucopyranoside
beta-d-galp-(1->6)-beta-d-galp-(1->6)-beta-d-galp-(1->6)-alpha-d-glcp-(1<->2)-beta-d-fruf
verbascose [mi]
glucopyranoside, .beta.-d-fructofuranosyl o-.alpha.-d-galactopyranosyl-(1-6)-o-.alpha.-d-galactopyranosyl-(1-6)-o-.alpha.-d-galactopyranosyl-(1-6)-, .alpha.-d-
SCHEMBL38437
surecn38437
56217_fluka
(2s,3r,4s,5r,6r)-2-[[(2r,3r,4s,5r,6s)-6-[[(2r,3r,4s,5r,6s)-6-[[(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-yl]methoxy]-3,4,5-trihydroxy-tetrahydropyran-2-yl]methoxy]-3,4
verbascose, analytical standard
Q12912931
DTXSID10969856
hex-2-ulofuranosyl hexopyranosyl-(1->6)hexopyranosyl-(1->6)hexopyranosyl-(1->6)hexopyranoside
HY-N9369
CS-0159547

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Treatment with verbascose at a dose of 200 μg/mL exhibited the best effects."( Immunomodulatory activity in vitro and in vivo of verbascose from mung beans (Phaseolus aureus).
Dai, Z; Hu, B; Jabbar, S; Su, D; Sun, Y; Ye, H; Zeng, X; Zhang, Y, 2014)		1

Bioavailability

ExcerptReferenceRelevance
" Application of Lactobacillus in the fermentation procedure increased tempeh protein and in vitro protein bioavailability by 18 and 17% respectively."( Effect of controlled lactic acid fermentation on selected bioactive and nutritional parameters of tempeh obtained from unhulled common bean (Phaseolus vulgaris) seeds.
Mickowska, B; Starzyńska-Janiszewska, A; Stodolak, B, 2014)		0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
pentasaccharideAn oligomer comprising five monomeric monosaccharide units.
raffinose family oligosaccharideAny oligosaccharide that has a biosynthetic pathway in common with that of raffinose.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
ajugose biosynthesis II (galactinol-independent)16
ajugose biosynthesis I (galactinol-dependent)25
ajugose biosynthesis I (galactinol-dependent)15

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (8.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's10 (83.33)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.92 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index103.53 (26.88)
Search Engine Supply Index2.97 (0.95)

This Compound (47.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
lactic acid
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed). 2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.		2.1102-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
phytic acid
Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.. myo-inositol hexakisphosphate : A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.		2.0810inositol phosphate
niacin
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.. vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).. nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.		2.0810pyridine alkaloid;
pyridinemonocarboxylic acid;
vitamin B3		antidote;
antilipemic drug;
EC 3.5.1.19 (nicotinamidase) inhibitor;
Escherichia coli metabolite;
human urinary metabolite;
metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
sucrose
Saccharum: A plant genus of the family POACEAE widely cultivated in the tropics for the sweet cane that is processed into sugar.		7.4820glycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
galactose
aldohexose : A hexose with a (potential) aldehyde group at one end.		1.9310
procyanidin
Proanthocyanidins: Dimers and oligomers of flavan-3-ol units (CATECHIN analogs) linked mainly through C4 to C8 bonds to leucoanthocyanidins. They are structurally similar to ANTHOCYANINS but are the result of a different fork in biosynthetic pathways.		2.110proanthocyanidin
raffinose
Raffinose: A trisaccharide occurring in Australian manna (from Eucalyptus spp, Myrtaceae) and in cottonseed meal.. raffinose : A trisaccharide composed of alpha-D-galactopyranose, alpha-D-glucopyranose and beta-D-fructofuranose joined in sequence by 1->6 and 1<->2 glycosidic linkages, respectively.		8.250raffinose family oligosaccharide;
trisaccharide		mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
stachyose
stachyose: RN given refers to parent cpd. stachyose : A tetrasaccharide consisting of sucrose having an alpha-D-galactosyl-(1->6)-alpha-D-galactosyl moiety attached at the 6-position of the glucose.		8.7390raffinose family oligosaccharide;
tetrasaccharide		mouse metabolite;
plant metabolite
beta-escin
[no description available]		2.0810
tannins
Tannins: Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS). The two main types are HYDROLYZABLE TANNINS and CONDENSED TANNINS. Historically, the term has applied to many compounds and plant extracts able to render skin COLLAGEN impervious to degradation. The word tannin derives from the Celtic word for OAK TREE which was used for leather processing.		2.0810
ascorbic acid
Ascorbic Acid: A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant.. L-ascorbic acid : The L-enantiomer of ascorbic acid and conjugate acid of L-ascorbate.. L-ascorbate : The L-enantiomer of ascorbate and conjugate base of L-ascorbic acid, arising from selective deprotonation of the 3-hydroxy group. Required for a range of essential metabolic reactions in all animals and plants.. vitamin C : Any member of a group of vitamers that belong to the chemical structural class called butenolides that exhibit biological activity against vitamin C deficiency in animals. The vitamers include L-ascorbic acid and its salt, ionized and oxidized forms.		2.0810ascorbic acid;
vitamin C		coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent
ConditionIndicatedRelationship StrengthStudiesTrials
Delayed Hypersensitivity
[description not available]		02.110